Frankenfield Christopher James (CIK 1988344) reported 2 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-01-05). Recent activity: Buy XLO (19,375 shares), Sell XLO (7,030 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-01-05 | Xilio Therapeutics, Inc. (XLO) | Chief Financial Officer | Buy | 19,375 | $0 |
| 2026-01-05 | Xilio Therapeutics, Inc. (XLO) | Chief Financial Officer | Sell | 7,030 | $0 |
Source: SEC Form 4 filings · as of 2026-01-05